Patents by Inventor Jeffry Curtis

Jeffry Curtis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POTATO PROTEIN POWDERS
    Publication number: 20180289036
    Abstract: Methods for making wettable, dispersible potato protein powders are provided. The wettable dispersible potato protein powders comprise potato protein, free amino acids, non-protein nitrogen compounds, and minerals from potatoes; and are low in total ?-glycoalkaloids. The inventive potato protein powders are suitable for use in formulating foods, feeds and beverages.
    Type: Application
    Filed: March 29, 2018
    Publication date: October 11, 2018
    Inventors: Jeffri Curtis BOHLSCHEID, Katrina Marie FLETCHER, Lee Meryl HUFFMAN
  • Raf Modulators and Methods of Use
    Publication number: 20080009488
    Abstract: The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly Raf. Methods of using the compounds and pharmaceutical compositions thereof to treat kinase-dependent diseases and conditions are also an aspect of the invention.
    Type: Application
    Filed: March 25, 2005
    Publication date: January 10, 2008
    Applicant: EXELIXIS, INC.
    Inventors: Neel Anand, Charles Blazey, Owen Bowles, Joerg Bussenius, Simona Costanzo, Jeffry Curtis, Larisa Dubenko, Abigail Kennedy, Steven Defina, Angie Kim, Jean-Claire Manalo, Csaba Peto, Kenneth Rice, Tsze Tsang, Anagha Joshi
  • Anaplastic lymphoma kinase modulators and methods of use
    Publication number: 20070032515
    Abstract: The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.
    Type: Application
    Filed: July 23, 2004
    Publication date: February 8, 2007
    Applicant: Exelixis, Inc.
    Inventors: Neel Anand, Charles Blazey, Owen Bowles, Joerg Bussenius, Simona Costanzo, Jeffry Curtis, Larisa Dubenko, Abigail Kennedy, Richard Khoury, Angie Kim, Jean-Claire Manalo, Csaba Peto, Kenneth Rice, Tsze Tsang